Company recalls compounded drug products
PharMEDium Services LLC has recalled 55 lots of compounded drug products due to a lack of sterility assurance, the Food and Drug Administration announced last week. The products were distributed to U.S. hospitals and clinics. Customers with recalled products should immediately quarantine and destroy them, and may report associated adverse reactions or quality problems to the FDA's MedWatch program.
Related News Articles
Headline
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:Certain lots of…
Headline
Randy Fagin, M.D., chief quality officer at HCA Healthcare, shares insights into the organization’s bold approach to improving safety outcomes. From piloting…
Headline
The AHA Quest for Quality Prize honors hospitals and health systems committed to leadership and innovation in improving quality and advancing health. Learn how…
Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Blog
Read about the 2025 Quest for Quality Prize winner and finalist — and apply for the 2026 awardEach day, health care professionals across the U.S. leverage…
Headline
A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional long-term IV therapy for treating…